Article Text

Download PDFPDF

083PS Incorporating Guidelines into Local Clinical Practice and Policy Through the Use of Practice-Based Health Technology Assessment
  1. Umscheid C1,2,3,
  2. Koster M4,
  3. Marchetti M5,6,
  4. Helfand M7,8,9,
  5. Wyer P3,10
  1. 1Penn Medicine Center for Evidence-based Practice, Philadelphia, PA, USA ECRI - Penn
  2. 2AHRQ Evidence-based Practice Center, Philadelphia, PA, USA
  3. 3Section of Evidence Based Health Care (SEBHC), New York Academy of Medicine, NY, USA
  4. 4Technology Assessment and Guidelines Unit, Kaiser Permanente, Pasadena, CA, USA
  5. 5HTA Unit of the Catholic University Hospital, Rome, Italy
  6. 6HTA International Interest Group on Hospital Based HTA Edmonton, Alberta, Canada
  7. 7Veterans Affairs Evidence-based Synthesis Program Portland, OR, USA
  8. 8Scientific Resource Center, AHRQ EPC Program Portland, OR, USA
  9. 9Oregon Health and Sciences University Portland, OR, USA
  10. 10Columbia University College of Physicians and Surgeons NY, USA


Background Practice-based health technology assessment (PB-HTA) has the potential to improve the quality, safety and value of patient care by synthesising evidence to provide timely guidance for clinical practice, policy, formulary management, operations, and purchasing decisions. Hospital-based HTA centres are active in Western Europe and Canada, but less so in the US, and some operate in conjunction with formal evidence-based guideline programmes.

Objectives/Goals To actively engage leaders of PB-HTA to discuss strengths and limitations, lessons learned, and the role of PB-HTA in the development, dissemination, and implementation of guidance within health care systems.

Target Group/Suggested Audience Senior executives/administrators, and clinical policy, quality and safety leaders in healthcare organisations and networks who develop, implement and measure performance related to clinical guidance.

Description of Aession and Speaker Topics Dr. Wyer, who leads a PB-HTA capacity building programme for health care organisations at the NYAM SEBHC, will engage the panellists in a discussion of their experiences leading PB-HTA efforts at Kaiser Permanente (Ms. Koster), the Veterans Administration (Dr. Helfand), Penn Medicine (Dr. Umscheid) and the HTA unit at the Catholic University Hospital in Rome, Italy (Dr. Marchetti). The discussion will address the potential for guidance developed by PB-HTA centres to impact the quality, safety and value of patient care, similarities and differences in national and international efforts, and future directions for the field.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.